Additional file 1: of Safety of direct oral anticoagulants in patients with hereditary hemorrhagic telangiectasia

Shovlin, C.; Millar, C.; Droege, F.; Kjeldsen, A.; Manfredi, G.; Suppressa, P.; Ugolini, S.; Coote, N.; Fialla, A.; Geisthoff, U.; Lenato, G.; Mager, H.; Pagella, F.; Post, M.; SabbĂ, C.; Sure, U.; Torring, P.; Dupuis-Girod, S.; Buscarini, E.

doi:10.6084/m9.figshare.9745877.v1

13023_2019_1179_MOESM1_ESM.pdf (403.38 kB)

Additional file 1: of Safety of direct oral anticoagulants in patients with hereditary hemorrhagic telangiectasia

journal contribution

posted on 2019-08-29, 04:55 authored by C. Shovlin, C. Millar, F. Droege, A. Kjeldsen, G. Manfredi, P. Suppressa, S. Ugolini, N. Coote, A. Fialla, U. Geisthoff, G. Lenato, H. Mager, F. Pagella, M. Post, C. SabbĂ, U. Sure, P. Torring, S. Dupuis-Girod, E. Buscarini

Table S1. Details of individual patients and treatments. (PDF 403 kb)

Funding

European Union

History

Usage metrics

Keywords

Apixaban Atrial fibrillation Dabigatran Epistaxis Heparin Pulmonary emboli Rivaroxaban Venous thromboemboli Warfarin

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Additional file 1: of Safety of direct oral anticoagulants in patients with hereditary hemorrhagic telangiectasia

Funding

European Union

History

Usage metrics

Categories

Keywords

Licence

Exports